Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) Director Karen Flynn sold 1,493 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the completion of the transaction, the director directly owned 5,757 shares of the company’s stock, valued at €98,387.13. This trade represents a 20.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Stevanato Group Price Performance
Shares of STVN opened at €17.79 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.63 and a quick ratio of 1.11. Stevanato Group S.p.A. has a 1-year low of €12.89 and a 1-year high of €28.00. The stock has a market cap of $5.39 billion, a PE ratio of 30.15, a price-to-earnings-growth ratio of 1.64 and a beta of 0.78. The firm has a fifty day moving average price of €17.47 and a 200 day moving average price of €17.23.
Stevanato Group (NYSE:STVN – Get Free Report) last posted its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing the consensus estimate of €0.12 by (€0.01). The firm had revenue of €273.57 million during the quarter. Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.10 earnings per share. As a group, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.68 EPS for the current year.
Stevanato Group Cuts Dividend
Analyst Upgrades and Downgrades
STVN has been the topic of a number of recent analyst reports. Citigroup dropped their price objective on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a report on Thursday, March 5th. Weiss Ratings raised Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, June 18th. KeyCorp decreased their target price on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research report on Thursday, March 5th. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Finally, Morgan Stanley cut their price target on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, March 6th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Stevanato Group presently has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on Stevanato Group
Hedge Funds Weigh In On Stevanato Group
Several hedge funds have recently bought and sold shares of the stock. State of Wyoming raised its holdings in Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after acquiring an additional 2,353 shares during the last quarter. GW&K Investment Management LLC grew its position in shares of Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after purchasing an additional 1,055 shares during the period. Quantbot Technologies LP acquired a new position in Stevanato Group in the third quarter valued at $68,000. Fifth Third Bancorp lifted its position in Stevanato Group by 22.6% during the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after buying an additional 773 shares during the period. Finally, Tower Research Capital LLC TRC boosted its stake in Stevanato Group by 1,268.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after buying an additional 4,250 shares during the last quarter.
About Stevanato Group
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
See Also
- Five stocks we like better than Stevanato Group
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
